CN102302583B - Medicinal composition for reducing swelling and alleviating pain - Google Patents

Medicinal composition for reducing swelling and alleviating pain Download PDF

Info

Publication number
CN102302583B
CN102302583B CN 201110223511 CN201110223511A CN102302583B CN 102302583 B CN102302583 B CN 102302583B CN 201110223511 CN201110223511 CN 201110223511 CN 201110223511 A CN201110223511 A CN 201110223511A CN 102302583 B CN102302583 B CN 102302583B
Authority
CN
China
Prior art keywords
parts
alleviating pain
reducing swelling
grams
medicinal composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN 201110223511
Other languages
Chinese (zh)
Other versions
CN102302583A (en
Inventor
梁兴涛
Original Assignee
梁兴涛
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 梁兴涛 filed Critical 梁兴涛
Priority to CN 201110223511 priority Critical patent/CN102302583B/en
Publication of CN102302583A publication Critical patent/CN102302583A/en
Application granted granted Critical
Publication of CN102302583B publication Critical patent/CN102302583B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention relates to a medicinal composition for reducing swelling and alleviating pain. The medicinal composition comprises the following raw materials in parts by weight: 12 parts of Chinese angelica, 10 parts of safflower, 10 parts of frankincense, 10 parts of myrrh, 12 parts of peony bark, 10 parts of dandelion, 15 parts of trichosanthes root, 10 parts of rhizoma corydalis, 12 parts of peach kernels, and 6 parts of liquorice. The medicinal composition has the effects of activating blood circulation to remove stasis, and reducing swelling and alleviating pain, and can be used for treating swelling and pains in bone fracture.

Description

A kind of pharmaceutical composition of reducing swelling and alleviating pain
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of pharmaceutical composition of reducing swelling and alleviating pain.
Background technology
In daily life, people are often perplexed by osteopathia, and the redness that wherein especially causes with fracture and distending pain etc. are for very.In order to solve these miseries, people have carried out a large amount of research, but effect is not desirable especially.
Summary of the invention
The pharmaceutical composition that the purpose of this invention is to provide a kind of reducing swelling and alleviating pain.
In order to realize purpose of the present invention, the invention provides a kind of pharmaceutical composition of reducing swelling and alleviating pain, it comprises following crude drug by weight: 6 parts in 12 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 10 parts of Olibanums, 10 parts of Myrrhas, 12 parts of Cortex Moutans, 10 parts of Herba Taraxacis, 15 parts of Radix Trichosanthis, 10 parts of Rhizoma Corydalis, 12 parts in Semen Persicae and Radix Glycyrrhizae.
Preferably, the pharmaceutical composition of reducing swelling and alleviating pain of the present invention also comprises following crude drug by weight: 7 10 parts of 7 10 parts of Eriocheir sinensiss and clasps.
Preferably, the pharmaceutical composition of reducing swelling and alleviating pain of the present invention can be made tablet, dispersible tablet, pill or unguentum.
Pharmaceutical composition blood circulation promoting and blood stasis dispelling of the present invention, reducing swelling and alleviating pain, redness, distending pain when can be used for treating fracture.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 pill of the present invention
Radix Angelicae Sinensis 12 grams, Flos Carthami 10 grams, Olibanum 10 grams, Myrrha 10 grams, Cortex Moutan 12 grams, Herba Taraxaci 10 grams, Radix Trichosanthis 15 grams, Rhizoma Corydalis 10 grams, Semen Persicae 12 grams and Radix Glycyrrhizae 6 grams are ground into fine powder, cross 80 mesh sieves, mixing.Every 100g powder adds the water of refined honey 40g and 10 grams, general ball, and drying is made 100 pills.
The preparation of embodiment 2 pills of the present invention
Radix Angelicae Sinensis 12 grams, Flos Carthami 10 grams, Olibanum 10 grams, Myrrha 10 grams, Cortex Moutan 12 grams, Herba Taraxaci 10 grams, Radix Trichosanthis 15 grams, Rhizoma Corydalis 10 grams, Semen Persicae 12 grams, Radix Glycyrrhizae 6 grams, Eriocheir sinensis 7 10 grams and clasp 7 10 grams are ground into fine powder, cross 80 mesh sieves, mixing.Every 100g powder adds the water of refined honey 40g and 10 grams, general ball, and drying is made 100 pills.
Experimental example
Select 50 examples through the maneuver outer fixing fracture patient that resets, male 25 examples wherein, women 25 examples, 35 years old mean age.Be divided into two groups, every group of 25 examples.
Inclusive criteria: take the photograph the fracture patient that sheet confirms through x-ray; Through maneuver reset or reduction by traction after the person that reaches at the functional reduction; Outer fixing definite person; Closed fracture; The AO classification of fracture site skin injury (Liu Yunpeng, Liu Yi. diagnostic classification and the hand functional evaluation standard [M] of B﹠J damage and disease. Beijing: publishing house of Tsing-Hua University, 2002:7.)≤IC 2Exclusion standard: the person of being treated surgically; Age of sucking or pregnancy women; The allergic constitution person; The poor person of compliance; Merge the serious primary disease person such as hemopoietic system and hormonal system; The person that takes the analgesic drug product simultaneously.
The pill of preparation among oral embodiment 1 and the embodiment 2, every day 3 times, each 10.30 days is a course for the treatment of.
Respectively at take medicine the same day and take medicine after detected affected part pain, tenderness or vertical button pain situation on the 3rd, 7,14,30 day, and carry out the VAS scoring (Duan Desheng is etc. surgery [M] for Chen Xiaoping, Shi Yingkang. Beijing: the People's Health Publisher, 2002:177.).Wherein the pill of embodiment 1 is respectively 9.8,5.3,3.8,2.1,1.9 the 0th, 3,7,14,30 day scoring; The pill of embodiment 2 is respectively 9.7,4.5,2.9,1.1,0.3 the 0th, 3,7,14,30 day scoring.This shows that the therapeutic effect of the pill of embodiment 2 will obviously be better than the therapeutic effect of the pill of embodiment 1.
After healing, all patients are followed up a case by regular visits to once weekly, in one month, do not find patient's disease relapse and significantly untoward reaction.

Claims (2)

1. the pharmaceutical composition of a reducing swelling and alleviating pain is characterized in that, it is made by following crude drug by weight:
7 10 parts of 12 parts of Radix Angelicae Sinensis, 10 parts on Flos Carthami, 10 parts of Olibanums, 10 parts of Myrrhas, 12 parts of Cortex Moutans, 10 parts of Herba Taraxacis, 15 parts of Radix Trichosanthis, 10 parts of Rhizoma Corydalis, 12 parts in Semen Persicae, 6 parts in Radix Glycyrrhizae, 7 10 parts of Eriocheir sinensiss and clasps.
2. the pharmaceutical composition of reducing swelling and alleviating pain according to claim 1 is characterized in that, described pharmaceutical composition is made tablet, pill or unguentum.
CN 201110223511 2011-08-05 2011-08-05 Medicinal composition for reducing swelling and alleviating pain Active CN102302583B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 201110223511 CN102302583B (en) 2011-08-05 2011-08-05 Medicinal composition for reducing swelling and alleviating pain

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 201110223511 CN102302583B (en) 2011-08-05 2011-08-05 Medicinal composition for reducing swelling and alleviating pain

Publications (2)

Publication Number Publication Date
CN102302583A CN102302583A (en) 2012-01-04
CN102302583B true CN102302583B (en) 2013-02-20

Family

ID=45376566

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 201110223511 Active CN102302583B (en) 2011-08-05 2011-08-05 Medicinal composition for reducing swelling and alleviating pain

Country Status (1)

Country Link
CN (1) CN102302583B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106361865A (en) * 2016-11-03 2017-02-01 陕西中医药大学第二附属医院 Traditional Chinese medicine capable of clearing away heat and toxic materials, cooling and activating blood and relieving swelling and pain

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101502615B (en) * 2009-02-10 2011-02-16 温志民 Plaster for traumatic injury and bone fracture

Also Published As

Publication number Publication date
CN102302583A (en) 2012-01-04

Similar Documents

Publication Publication Date Title
CN102274252B (en) Stauntonvine external applied preparation for treating rheumatoid diseases and preparation method thereof
CN105381132A (en) Drug for treating thyroid nodule
CN102526307A (en) Chinese medicinal composition for treating herpes zoster
CN102657785A (en) Medicinal composition for treating gingivitis
CN102302583B (en) Medicinal composition for reducing swelling and alleviating pain
CN103705846A (en) Traditional Chinese medicine preparation for treating ovarian cyst
CN104623376B (en) Be used for the treatment of prosopalgic medicine
CN102283972B (en) Pharmaceutical composition for treating rib fracture
CN105362382A (en) Traditional Chinese medicine composition for treating recurrent oral ulcer and application thereof
CN102526385B (en) Medicament for treating climacteric syndrome
CN102293880B (en) External Chinese herbal preparation for treating bedsore and preparation method thereof
CN101810831B (en) Medicament for treating gynecological diseases
CN102579617A (en) Traditional Chinese medicine capsule for treating chronic neck, shoulder, waist and leg pains and processing method of same
CN102716183B (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN102727831B (en) Traditional Chinese medicine for treating cholelithiasis
CN103239646B (en) Chinese medicine effective part composition for treating leucoderma and preparation method thereof
CN103006995B (en) Medicine for treating post-dural puncture headache (PDPHA)
CN103055051B (en) Liquid for treating burn and scald
CN102631633B (en) Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
CN104825809A (en) Medicament for treating peripheral facial paralysis
CN103142960B (en) Medicament for treating skin diseases
CN103845509A (en) Traditional Chinese medicine for treating systemic cutaneous pruritus
CN103860982B (en) A kind of clinical care is treated the medicine of acute skin injury induced by iradiation
CN103083639B (en) Medicament for treating postpartum pain of body
CN102772544B (en) A kind of cream drug for the treatment of scrotum scabies

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant